Observational Study of the Effect of Pirfenidone on Cough in Patients With Idiopathic Pulmonary Fibrosis
Phase of Trial: Phase IV
Latest Information Update: 26 Dec 2016
Price : $35 *
At a glance
- Drugs Pirfenidone (Primary)
- Indications Pulmonary fibrosis
- Focus Therapeutic Use
- Acronyms Cough-IPF
- 21 Dec 2016 Status changed from active, no longer recruiting to completed.
- 29 Oct 2016 Planned End Date changed from 1 Oct 2016 to 1 Nov 2016.
- 29 Oct 2016 Planned primary completion date changed from 1 May 2016 to 1 Oct 2016.